Full Text View
Tabular View
No Study Results Posted
Related Studies
Efficacy of an Exercise Intervention to Decrease Depressive Symptoms in Veterans With Hepatitis C
This study is enrolling participants by invitation only.
First Received: March 20, 2008   No Changes Posted
Sponsored by: Portland VA Medical Center
Information provided by: Portland VA Medical Center
ClinicalTrials.gov Identifier: NCT00643695
  Purpose

In this study, depressed veterans with hepatitis C will be randomly assigned to the control group or to the exercise intervention group. The exercise intervention is designed to begin slowly for most participants and to progress within each participant's target heart rate range for moderate intensity exercise. The exercise intervention is a 12 week home based walking program. Ideally individuals will walk for 30 minutes, at a moderate intensity, a minimum of three times per week. However, the duration and relative intensity will be tailored for each individual.

Central Hypothesis Veterans who receive the exercise intervention will be significantly less symptomatic for depression than veterans in the control group.


Condition Intervention
Hepatitis C
Depression
Behavioral: Home-based walking program
Other: Educational intervention

MedlinePlus related topics: Depression Exercise and Physical Fitness Hepatitis Hepatitis C
U.S. FDA Resources
Study Type: Interventional
Study Design: Treatment, Randomized, Open Label, Parallel Assignment, Efficacy Study
Official Title: Efficacy of an Exercise Intervention to Decrease Depressive Symptoms in Veterans With Hepatitis C

Further study details as provided by Portland VA Medical Center:

Primary Outcome Measures:
  • Reduction of symptoms of depression as measured by the Beck Depression Inventory II (BDI-II) [ Time Frame: 12 weeks ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Reduction in symptoms of fatigue as measured by the Brief Fatigue Inventory (BFI) [ Time Frame: 12 weeks ] [ Designated as safety issue: No ]
  • reduce the reported level of chronic pain [ Time Frame: 12 weeks ] [ Designated as safety issue: No ]

Estimated Enrollment: 56
Study Start Date: March 2008
Estimated Primary Completion Date: June 2010 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
1: Experimental
Home-based walking program
Behavioral: Home-based walking program
The exercise intervention is a 12 week home-based exercise program. Ideally Individuals will walk for 30 minutes, at a moderate intensity, a minimum of three times per week. However, the duration and relative intensity will be tailored for each individual.
2: No Intervention Other: Educational intervention
Participants in the control group will receive a packet of information regarding hepatitis C

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Male or female, age 18 or older
  • Documentation of positive hepatitis C status as indicated by a detectable HCV viral load by polymerase chain reaction
  • Mild to moderate depressive symptoms as evidenced by a BDI II score of ≥ 14
  • Able to read and understand English
  • Written/signed informed consent specific to this protocol
  • Being sedentary that is , less than 30 minutes of planned low to moderate intensity exercise 2 days per week

Exclusion Criteria:

  • Suicidal ideations
  • Current interferon therapy or planning to begin interferon therapy during the next three months
  • Diagnosis of Bipolar disorder, Schizophrenia, or Post Traumatic Stress Disorder
  • Any medical condition, disorder, or medication that contraindicates participation in a mild to moderate intensity walking program
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00643695

Locations
United States, Oregon
Portland VA Medical Center
Portland, Oregon, United States, 97239
Sponsors and Collaborators
Portland VA Medical Center
Investigators
Principal Investigator: Patricia Taylor-Young, PhD, RN,FNP Portland VA Medical Center
  More Information

No publications provided

Responsible Party: Portland VA Medical Center ( Patricia Taylor-Young PhD RN NP )
Study ID Numbers: 02101
Study First Received: March 20, 2008
Last Updated: March 20, 2008
ClinicalTrials.gov Identifier: NCT00643695     History of Changes
Health Authority: United States: Federal Government

Keywords provided by Portland VA Medical Center:
hepatitis C
depression
exercise

Study placed in the following topic categories:
Virus Diseases
Hepatitis
Liver Diseases
Digestive System Diseases
Depression
Mental Disorders
Mood Disorders
Hepatitis, Viral, Human
Hepatitis C
Depressive Disorder
Behavioral Symptoms

Additional relevant MeSH terms:
Liver Diseases
RNA Virus Infections
Depression
Flaviviridae Infections
Hepatitis, Viral, Human
Depressive Disorder
Behavioral Symptoms
Hepatitis
Virus Diseases
Digestive System Diseases
Mental Disorders
Mood Disorders
Hepatitis C

ClinicalTrials.gov processed this record on May 07, 2009